SLNOW - (Soleno Therapeutics Inc.)

 SLNOWのチャート


 SLNOWの企業情報

symbol SLNOW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種   
概要 事業概要 --     Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2014年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/slnow
adr_tso
EBITDA EBITDA ー
終値(lastsale) 0.1
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 SLNOWのテクニカル分析


 SLNOWのニュース

   Soleno Therapeutics Inc (NASDAQ:SLNO) Expected to Post Earnings of -$0.17 Per Share  2019/11/08 11:14:51 Modern Readers
Analysts expect Soleno Therapeutics Inc (NASDAQ:SLNO) to announce earnings of ($0.17) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Soleno Therapeutics’ earnings. Soleno Therapeutics posted earnings per share of ($0.11) in the same quarter last year, which indicates a negative year over year growth rate […]
   Capnia, Inc. (SLNO) Upgraded to Strong Buy: Here's What You Should Know  2019/07/15 13:00:07 Zacks Investment Research
Capnia, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
   Soleno Therapeutics beats by $0.07  2019/05/13 12:06:36 Seeking Alpha
   Soleno Therapeutics (SLNO) to Post Q1 Earnings: What's Up?  2019/05/06 20:13:00 Zacks Investment Research
During Soleno Therapeutics' (SLNO) Q1 conference call, investor focus will be on its progress with the ongoing study on DCCR tablets, developed for the treatment of Prader-Willi syndrome.
   Are You Looking for a Top Momentum Pick? Why Capnia, Inc. (SLNO) is a Great Choice  2019/03/25 14:00:07 Zacks Investment Research
Does Capnia, Inc. (SLNO) have what it takes to be a top stock pick for momentum investors? Let's find out.
   Soleno Therapeutics Inc (NASDAQ:SLNO) Expected to Post Earnings of -$0.17 Per Share  2019/11/08 11:14:51 Modern Readers
Analysts expect Soleno Therapeutics Inc (NASDAQ:SLNO) to announce earnings of ($0.17) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Soleno Therapeutics’ earnings. Soleno Therapeutics posted earnings per share of ($0.11) in the same quarter last year, which indicates a negative year over year growth rate […]
   Capnia, Inc. (SLNO) Upgraded to Strong Buy: Here's What You Should Know  2019/07/15 13:00:07 Zacks Investment Research
Capnia, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
   Soleno Therapeutics beats by $0.07  2019/05/13 12:06:36 Seeking Alpha
   Soleno Therapeutics (SLNO) to Post Q1 Earnings: What's Up?  2019/05/06 20:13:00 Zacks Investment Research
During Soleno Therapeutics' (SLNO) Q1 conference call, investor focus will be on its progress with the ongoing study on DCCR tablets, developed for the treatment of Prader-Willi syndrome.
   Are You Looking for a Top Momentum Pick? Why Capnia, Inc. (SLNO) is a Great Choice  2019/03/25 14:00:07 Zacks Investment Research
Does Capnia, Inc. (SLNO) have what it takes to be a top stock pick for momentum investors? Let's find out.

 関連キーワード  (― 米国株 SLNOW Soleno Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)